Physician

Acquawon Jean Stallworth, MD

According to 2025 Medicare claims, Acquawon Stallworth, MD (NPI: 1336135623) practices family practice in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from Rowan, NC. This provider's primary affiliated billing organization is NOVANT HEALTH MEDICAL GROUP, LLC (NPI: 1134841802; TIN: 581728803) and primary practice location at 28147-1177. Stallworth is affiliated with the Novant Health Accountable Care Organization I, LLC (ACO ID: A3504), participating under the MSSP model.

Stallworth's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 125 traditional Medicare patients, billed 836 HCPCS/CPT codes, and received $39,574 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 17,484 prescription claims across 983 beneficiaries totaling $1,673,590 in drug costs, led by Ozempic (Semaglutide). DME data shows 129 claims. Open Payments data shows 1 records totaling $100. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $732,368 to $1,673,590. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $17,674 and ending at $17,174.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	202	1,706	$62,999
2016	205	1,459	$52,649
2017	203	1,667	$54,579
2018	173	1,640	$61,818
2019	160	1,390	$48,635
2020	162	1,167	$47,526
2021	203	1,133	$54,021
2022	175	1,038	$47,437
2023	142	929	$44,185
2024	125	836	$39,574

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	396	13,932	$732,368
2016	431	13,773	$709,279
2017	407	12,761	$718,675
2018	512	11,122	$690,239
2019	783	11,021	$840,601
2020	619	10,972	$857,014
2021	777	11,649	$907,585
2022	760	14,849	$1,406,196
2023	952	16,702	$1,706,045
2024	983	17,484	$1,673,590

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	132	499	$18,676
2016	67	423	$10,512
2017	65	268	$8,510
2018	42	253	$6,958
2019	30	250	$4,633
2020	13	107	$1,974
2021	23	141	$5,501
2022	N/R	150	$10,478
2023	N/R	144	$12,896
2024	N/R	129	$12,482

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	86	86	$121
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	91	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	84	159	$47
36415	Insertion of needle into vein for collection of blood sample	69	95	$9
96127	Assessment of emotional or behavioral problems	49	50	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	198	7,598	$239,806
Jardiance	Empagliflozin	205	8,781	$175,885
Eliquis	Apixaban	250	8,320	$161,616
Mounjaro	Tirzepatide	81	2,296	$87,935
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	114	3,780	$81,881

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	25	$7,475
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	13	$2,025
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	22	$1,654
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	17	$440
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$369

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$100	Alexion Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Acquawon Jean Stallworth, MD?

Tedicare shows public-source Medicare data for Acquawon Jean Stallworth, MD (NPI 1336135623), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Acquawon Jean Stallworth, MD have ACO affiliation data?

Acquawon Jean Stallworth, MD is shown with ACO affiliation data for Novant Health Accountable Care Organization I, LLC (MSSP, ACO ID A3504).

What billing organization is linked to Acquawon Jean Stallworth, MD?

Acquawon Jean Stallworth, MD is linked to NOVANT HEALTH MEDICAL GROUP, LLC (billing NPI 1134841802) in the available physician profile data.

Does Acquawon Jean Stallworth, MD have Open Payments data?

Acquawon Jean Stallworth, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.